Healthcare Stocks Charging Up for Historic Highs: Prospect Capital Corporation (NASDAQ:PSEC), AGNC Investment (NASDAQ:AGNC)

Prospect Capital Corporation (NASDAQ:PSEC) runs in leading trade, it inching up 0.47% to traded at $8.63. PSEC attains analyst recommendation of 3.30 on scale of 1-5 with week’s performance of 0.58%.

To find out the technical position of PSEC, it holds price to book ratio of 0.90 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. It has forward price to earnings ratio of 8.88, and price to earnings ratio calculated as 19.66. The price to earnings growth ration calculated as 3.93. PSEC is presenting price to cash flow of 23.29 and free cash flow concluded as 13.31.

EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -70.40%, and looking further price to next year’s EPS is 4.29%. While take a short look on price to sales ratio, that was 3.99 and price to earning ration of 19.66 attracting passive investors.

AGNC Investment Corp. (NASDAQ:AGNC) kept active in under and overvalue discussion, AGNC holds price to book ratio of 0.82 that presents much better indicator to find market price of a share price over its book value of equity for investment valuation. In addition, the firm has price to earnings ratio of 40.60, which is authentic method to judge but not universal for all situation.

Fundament/ News Factor in Focus

Taking look on ratio analysis, AGNC has forward price to earnings ratio of 8.15, compare to its price to earnings ratio of 40.60. The co is presenting price to cash flow as 4.98 and while calculating price to free cash flow it concluded at 11.12, the low single digit may indicate stock is undervalued and vice versa. On other hand, keeping in mind stable cash flows but few growth prospects make traders to value lower.

The firm has price volatility of 1.37% for a week and 1.53% for a month. Its beta stands at 0.11 times. Narrow down four to firm performance, its weekly performance was -0.16% and monthly performance was 5.78%.


About Aaron Smithies

Aaron Smithies has a wide look on current monetary and financial events. He is an editor and a writer. His views; At Streetwise Report, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Interests: Biotech, Finical markets, Dividend stock ideas & income, Energy stocks, Consumer goods stocks

Leave a Reply

Your email address will not be published. Required fields are marked *